Pennsylvania biologics regulations.

Who may administer PRP, exosomes and stem cells in Pennsylvania, and which agencies to check.

A physician at a desk reading regulatory documents

Who may administer biologics in Pennsylvania?

In Pennsylvania, licensed medical practitioners, such as MDs and DOs, and advanced practice providers under physician supervision are authorized to administer stem cell therapies.

Official sources

Pennsylvania compliance guide.

FDA Compliance

Clinics must adhere to the FDA’s guidelines for Human Cells, Tissues, and Cellular and Tissue-Based Products (HCT/P). The most relevant sections include:

  • CBER Regulatory Guidance
  • 21 CFR Part 1271

Pennsylvania State Regulations

Pennsylvania’s Department of Health has specific guidelines and licensure requirements for providers. For more detailed information, visit the Pennsylvania Department of Health.

Provider Qualifications

In Pennsylvania, licensed medical practitioners, such as MDs and DOs, and advanced practice providers under physician supervision are authorized to administer stem cell therapies. Additional credentialing may be required based on the nature of the biologic treatments offered. It is important for providers to verify licensing requirements through the Pennsylvania State Licensing Board.

Patient Informed Consent

Patients must be provided with comprehensive informed consent documents outlining:

  • The experimental nature of certain biologic treatments
  • Potential risks and benefits
  • Alternatives to treatment. Ensure that consent forms meet both federal and state-specific standards.

Pre-Treatment and Post-Treatment Protocols

Clinics should establish clear SOPs for patient evaluation before treatment and follow-up protocols post-treatment to monitor efficacy and safety.

Medical Liability Insurance

Medical providers must maintain adequate malpractice insurance that covers biologic treatments. Consult with insurance specialists to tailor coverage to these services.

Marketing Compliance

All promotional materials should avoid misleading claims and clearly state FDA approval status if applicable. Reference the FTC guidelines for advertising for further compliance checks.

This guide is a general summary to help clinics understand compliance requirements for biologics in Pennsylvania. It is not legal advice. Regulations change; consult legal counsel and the agencies above before acting on it.

Pennsylvania: common questions.

Who can administer stem cells, PRP and exosomes in Pennsylvania?
In Pennsylvania, licensed medical practitioners, such as MDs and DOs, and advanced practice providers under physician supervision are authorized to administer stem cell therapies. This is a general summary, not legal advice. Confirm with the state board.
Are stem cell and exosome therapies FDA-approved in Pennsylvania?
FDA rules are federal, so they apply in Pennsylvania as everywhere else. Exosome and stem cell therapies are not FDA-approved for therapeutic use, and PRP applications are considered off-label.
Do I need an IRB-approved study to offer biologics in Pennsylvania?
Investigational treatment belongs inside a reviewed study with proper informed consent. IRB review is not FDA authorisation: culture-expanded and other more-than-minimally-manipulated cell products generally need an IND before use in people.
How do I start offering biologics in Pennsylvania?
Start with the live webinar, then a discovery call and live training. After that we verify your Pennsylvania licence, protocol, product sourcing, consent process and advertising before you are listed for patient inquiries.

Practising in Pennsylvania? Start with the webinar.

Live on Zoom, Tuesdays at 12:00 PM ET. See how the model works before you commit to anything.